BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1650650)

  • 1. Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619).
    Yun JC; Ohman KP; Gill JR; Keiser H
    Can J Physiol Pharmacol; 1991 May; 69(5):599-604. PubMed ID: 1650650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of prostaglandins with adenosine diphosphate induced increase in cytosolic free calcium in human platelets.
    Ohman KP; Yun JC; Keiser HR
    Scand J Clin Lab Invest; 1992 Oct; 52(6):483-90. PubMed ID: 1329185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor occupancy regulates Ca2+ entry and intracellular Ca2+ redistribution in activated human platelets.
    BrĂ¼ne B; von Appen F; Ullrich V
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):993-9. PubMed ID: 7818507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a prostaglandin I2 analog iloprost on cytoplasmic Ca2+ levels and muscle contraction in isolated guinea pig aorta.
    Ozaki H; Abe A; Uehigashi Y; Kinoshita M; Hori M; Mitsui-Saito M; Karaki H
    Jpn J Pharmacol; 1996 Jul; 71(3):231-7. PubMed ID: 8854205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17 beta-Estradiol inhibits Ca2+ influx and Ca2+ release induced by thromboxane A2 in porcine coronary artery.
    Han SZ; Karaki H; Ouchi Y; Akishita M; Orimo H
    Circulation; 1995 May; 91(10):2619-26. PubMed ID: 7743625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.
    Pollock WK; Armstrong RA; Brydon LJ; Jones RL; MacIntyre DE
    Biochem J; 1984 May; 219(3):833-42. PubMed ID: 6234886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.
    Astarie-Dequeker C; Korichneva I; Devynck MA
    Br J Pharmacol; 1995 Jan; 114(2):524-30. PubMed ID: 7881751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium.
    Packham MA; Kinlough-Rathbone RL; Mustard JF
    Blood; 1987 Sep; 70(3):647-51. PubMed ID: 3620698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
    Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium, calmodulin and protein kinase C dependence of platelet shape change.
    Dandona P; Thusu K; Khurana U; Love J; Aljada A; Mousa S
    Thromb Res; 1996 Jan; 81(2):163-75. PubMed ID: 8822131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of two thromboxane A2/prostaglandin H2 receptor ligands, U46619 and S-145, on rabbit platelets.
    Nakano T; Hanasaki K; Arita H
    FEBS Lett; 1988 Jul; 234(2):309-12. PubMed ID: 2968921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
    Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect regulation of Ca2+ entry by cAMP-dependent and cGMP-dependent protein kinases and phospholipase C in rat platelets.
    Heemskerk JW; Feijge MA; Sage SO; Walter U
    Eur J Biochem; 1994 Jul; 223(2):543-51. PubMed ID: 8055924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal platelet response to thromboxane A2.
    Wu KK; Le Breton GC; Tai HH; Chen YC
    J Clin Invest; 1981 Jun; 67(6):1801-4. PubMed ID: 6263954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.